References
- . American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33( suppl 1):S62–S69
- . National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28(12):1039–1057
- . The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183–1197
- . Maitra A. The endocrine system: diabetes mellitus. In: Kumar V, Abbas AK, Fausto N, Aster J, eds. Robbins and Cotran Pathologic Basis of Disease, Professional Edition. 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:1131–1146
- . American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31( suppl 1):S55–S60
- . Bandurska-Stankiewicz E, Praszkiewicz I, Surdykowski L. Latent autoimmune diabetes in adults—LADA diabetes. Diabetologia. 2006;6(4):173–181
- . Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care. 1999;22( suppl 2):B59–B64
- . Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001;24(8):1460–1467
- . Matejkova-Behanova M. Latent autoimmune diabetes in adults (LADA) and autoimmune thyroiditis. Endocr Regul. 2001;35(3):167–172
- . Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006;29(12):2755–2757
- . Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164(17):1925–1931
- . Chiasson JL, Aris-Jilwan N, Bélanger R,. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168(7):859–866
- . Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2005;71(9):1723–1730
- . Nathan DM. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347(17):1342–1349
- . Nathan DM, Buse JB, Davidson MB,. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203
- . Lepore M, Pampanelli S, Fanelli C,. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and Ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000;49(12):2142–2148
- . Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26(11):3080–3086
- . Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P; Levemir Treat-to-Target Study Group. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care. 2006;29(6):1269–1274
- . Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care. 2003;26(3):881–885
- . Dailey G. A timely transition to insulin: identifying type 2 diabetes patients failing oral therapy. Formulary. 2005;40(4):114–130
- . Becker RH, Frick AD. Clinical pharmacokinetics and pharmacodynamics of insulin glulisine. Clin Pharmacokinet. 2008;47(1):7–20
- . Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med. 2003;163(11):1306–1316
- . Kitabchi AE, Umpierrez GE, Murphy MB,; American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care. 2004;27( suppl 1):S94–S102